UCB | Profitto Lordo Sulle Vendite



Gross Profit On Sales Cambiamento Data
Alcon AG USD 1.39B 5M 2025-06
Almirall EUR 191.9M 185.49M 2025-03
Amarin USD 25.13M 1.78M 2025-03
argenx SE USD 837.21M 127.34M 2025-06
AstraZeneca USD 11.98B 637M 2025-06
Bayer EUR 6.38B 1.74B 2025-06
Galapagos EUR 61.25M 98.68M 2025-03
Genmab DKK 868M 195M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
GRIFOLS EUR 743.8M 49.13M 2025-06
Hikma Pharmaceutical USD 692M 64M 2024-12
Lonza CHF 1.04B 72M 2024-12
Merck EUR 3.03B 118M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Orion EUR 248.3M 46.5M 2025-06
Recordati EUR 423.85M 34.92M 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.74B 26M 2025-06
UCB EUR 2.46B 520M 2024-12
Unibail Rodamco EUR 997M 516.9M 2024-12


UCB Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.